InnoPharmax
About
About Us
Organization
Our History
News
News
R&D
Pipeline
Anti-infection Agents
Contrast Agents
Oncology Agents
Immunological Agents
Drugs for Rare Diseases
Active Pharmaceutical Ingredient
Products
GemOral
N11005
Technologies
OralPAS®
OralPAS Pro®
MUCR™
Investors
Financial Information
Company Profile
Monthly Revenue
Financial Statements
Corporate Governance
Board Meeting
Committee
Internal Audit
Rule of Procedure
Corporate Social Responsibility
Shareholders Services
Annual Reports
Shareholders' Meetings
Announcements
Contact
Contacts
Contact Information
Career Opportunities
ZH-TW
Product and Pipeline
Pipeline
Anti-infection Agents
Contrast Agents
Oncology Agents
Immunological Agents
Drugs for Rare Diseases
Active Pharmaceutical Ingredient
Bestnem®(Imipenem/Cilastatin)
>
Anti-infection Agents
>
Product and Pipeline
>
home
Bestnem®(Imipenem/Cilastatin)
Bestnem
®
(Imipenem/
Cilastatin)
Clicks:
9451
Imipenem and cilastatin sodium solution is used intravenous in the treatment of serious infections caused by susceptible organisms including lower respiratory tract, skin and skin structure, intra-abdominal, gynecologic, or bone and joint infections. The drug also is used intravenous in the treatment of serious complicated or uncomplicated urinary tract infections (UTIs), septicemia, or endocarditis caused by susceptible organisms. In August 2007,
INNOPHARMAX
had been granted the product license from DOH to market
BESTNEM
®
in Taiwan.
Back
uGear Design
-
Website Info.